Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 4/2016

01-12-2016

Molecular mimicry and autoimmune thyroid disease

Authors: Salvatore Benvenga, Fabrizio Guarneri

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2016

Login to get access

Abstract

Hypothesized 40 years ago, molecular mimicry has been thereafter demonstrated as an extremely common mechanism by which microbes elude immune response and modulate biosynthetic/metabolic pathways of the host. In genetically predisposed persons and under particular conditions, molecular mimicry between microbial and human antigens can turn a defensive immune response into autoimmunity. Such triggering role and its pathogenetic importance have been investigated and demonstrated for many autoimmune diseases. However, this is not the case for autoimmune thyroid disease, which appears relatively neglected by this field of research. Here we review the available literature on the possible role of molecular mimicry as a trigger of autoimmune thyroid disease. Additionally, we present the results of in silico search for amino acid sequence homologies between some microbial proteins and thyroid autoantigens, and the potential pathogenetic relevance of such homologies. Relevance stems from the overlap with known autoepitopes and the occurrence of specific HLA-DR binding motifs. Bioinformatics data published by our group support and explain the triggering role of Borrelia, Yersinia, Clostridium botulinum, Rickettsia prowazekii and Helicobacter pylori. Our new data suggest the potential pathogenic importance of Toxoplasma gondii, some Bifidobacteria and Lactobacilli, Candida albicans, Treponema pallidum and hepatitis C virus in autoimmune thyroid disease, indicating specific molecular targets for future research. Additionally, the consistency between in silico prediction of cross-reactivity and experimental results shows the reliability and usefulness of bioinformatics tools to precisely identify candidate molecules for in vitro and/or in vivo experiments, or at least narrow down their number.
Literature
1.
go back to reference Bates HW. Contributions to an insect fauna of the Amazon valley. Lepidoptera: Heliconidae. Trans Linnean Soc. 1862;23:495–566.CrossRef Bates HW. Contributions to an insect fauna of the Amazon valley. Lepidoptera: Heliconidae. Trans Linnean Soc. 1862;23:495–566.CrossRef
2.
go back to reference Müller F. Ueber die vortheile der mimicry bei schmetterlingen. Zool Anz. 1878;1:54–5. Müller F. Ueber die vortheile der mimicry bei schmetterlingen. Zool Anz. 1878;1:54–5.
3.
go back to reference Emsley MG. The mimetic significance of Erythrolamprus aesculapii ocellatus Peters from Tobago. Evolution. 1966;20:663–4.CrossRef Emsley MG. The mimetic significance of Erythrolamprus aesculapii ocellatus Peters from Tobago. Evolution. 1966;20:663–4.CrossRef
4.
go back to reference Wickler W. Mimicry in plants and animals. New York: McGraw-Hill; 1968. Wickler W. Mimicry in plants and animals. New York: McGraw-Hill; 1968.
5.
6.
go back to reference Guarneri F, Guarneri C. Molecular mimicry in cutaneous autoimmune diseases. World J Dermatol. 2013;2:36–43.CrossRef Guarneri F, Guarneri C. Molecular mimicry in cutaneous autoimmune diseases. World J Dermatol. 2013;2:36–43.CrossRef
7.
go back to reference Grossman Z, Paul WE. Autoreactivity, dynamic tuning and selectivity. Curr Opin Immunol. 2001;13:687–98.CrossRefPubMed Grossman Z, Paul WE. Autoreactivity, dynamic tuning and selectivity. Curr Opin Immunol. 2001;13:687–98.CrossRefPubMed
8.
9.
go back to reference Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst. 1999;91:1725–33.CrossRefPubMed Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst. 1999;91:1725–33.CrossRefPubMed
10.
go back to reference Shapiro RF, Wiesner KB, Bryan BL, Utsinger PD, Resnick D, Castles JJ. HLA-B27 and modified bone formation. Lancet. 1976;1:230–1.CrossRefPubMed Shapiro RF, Wiesner KB, Bryan BL, Utsinger PD, Resnick D, Castles JJ. HLA-B27 and modified bone formation. Lancet. 1976;1:230–1.CrossRefPubMed
11.
go back to reference Ebringer A. Ankylosing spondylitis, immune-response-genes and molecular mimicry. Lancet. 1979;1:1186.CrossRefPubMed Ebringer A. Ankylosing spondylitis, immune-response-genes and molecular mimicry. Lancet. 1979;1:1186.CrossRefPubMed
14.
go back to reference Fujinami RS, Oldstone MB. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res. 1989;8:3–15.CrossRefPubMed Fujinami RS, Oldstone MB. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res. 1989;8:3–15.CrossRefPubMed
15.
go back to reference Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 1998;19:395.CrossRefPubMed Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 1998;19:395.CrossRefPubMed
16.
go back to reference Anderton SM, Wraith DC. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol. 2002;2:487–98.CrossRefPubMed Anderton SM, Wraith DC. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol. 2002;2:487–98.CrossRefPubMed
17.
go back to reference Sospedra M, Martin R. When T cells recognize a pattern, they might cause trouble. Curr Opin Immunol. 2006;18:697–703.CrossRefPubMed Sospedra M, Martin R. When T cells recognize a pattern, they might cause trouble. Curr Opin Immunol. 2006;18:697–703.CrossRefPubMed
18.
go back to reference Ryan KR, Patel SD, Stephens LA, Anderton SM. Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun. 2007;29:262–71.CrossRefPubMed Ryan KR, Patel SD, Stephens LA, Anderton SM. Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun. 2007;29:262–71.CrossRefPubMed
19.
20.
go back to reference Ohashi PS. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol. 2002;2:427–38.PubMed Ohashi PS. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol. 2002;2:427–38.PubMed
21.
go back to reference Pasare C, Medzhitov R. Toll-like receptors: balancing host resistance with immune tolerance. Curr Opin Immunol. 2003;15:677–82.CrossRefPubMed Pasare C, Medzhitov R. Toll-like receptors: balancing host resistance with immune tolerance. Curr Opin Immunol. 2003;15:677–82.CrossRefPubMed
23.
go back to reference Anderson CC, Chan WF. Mechanisms and models of peripheral CD4 T cell self-tolerance. Front Biosci. 2004;9:2947–63.CrossRefPubMed Anderson CC, Chan WF. Mechanisms and models of peripheral CD4 T cell self-tolerance. Front Biosci. 2004;9:2947–63.CrossRefPubMed
24.
go back to reference Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P. Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol. 2002;14:354–9.CrossRefPubMed Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P. Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol. 2002;14:354–9.CrossRefPubMed
25.
go back to reference Guarneri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diabetes Obes. 2007;14:398–409.CrossRefPubMed Guarneri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diabetes Obes. 2007;14:398–409.CrossRefPubMed
26.
go back to reference Volpé R. A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder? Autoimmunity. 1992;13:3–9.CrossRefPubMed Volpé R. A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder? Autoimmunity. 1992;13:3–9.CrossRefPubMed
27.
go back to reference Toivanen P, Toivanen A. Does Yersinia induce autoimmunity? Int Arch Allergy Immunol. 1994;104:107–11.CrossRefPubMed Toivanen P, Toivanen A. Does Yersinia induce autoimmunity? Int Arch Allergy Immunol. 1994;104:107–11.CrossRefPubMed
28.
go back to reference Tomer Y, Davies TF. Infections and autoimmune endocrine disease. Bailliere Clin Endocrinol Metab. 1995;9:47–70.CrossRef Tomer Y, Davies TF. Infections and autoimmune endocrine disease. Bailliere Clin Endocrinol Metab. 1995;9:47–70.CrossRef
29.
go back to reference Martin A, Barbesino G, Davies TF. T-cell receptors and autoimmune thyroid disease–signposts for T-cell-antigen driven diseases. Int Rev Immunol. 1999;18:111–40.CrossRefPubMed Martin A, Barbesino G, Davies TF. T-cell receptors and autoimmune thyroid disease–signposts for T-cell-antigen driven diseases. Int Rev Immunol. 1999;18:111–40.CrossRefPubMed
30.
go back to reference Rao VP, Kajon AE, Spindler KR, Carayanniotis G. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease. J Immunol. 1999;162:5888–93.PubMed Rao VP, Kajon AE, Spindler KR, Carayanniotis G. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease. J Immunol. 1999;162:5888–93.PubMed
31.
go back to reference Carayanniotis G, Kong YC. Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis. Int Rev Immunol. 2000;19:557–72.CrossRefPubMed Carayanniotis G, Kong YC. Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis. Int Rev Immunol. 2000;19:557–72.CrossRefPubMed
32.
go back to reference Chen CR, Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B. A full biological response to autoantibodies in Graves’ disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain. J Biol Chem. 2001;276:14767–72.CrossRefPubMed Chen CR, Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B. A full biological response to autoantibodies in Graves’ disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain. J Biol Chem. 2001;276:14767–72.CrossRefPubMed
33.
go back to reference Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, Churchill D, de Ruiter A, Robinson S, Lacey CJ, Weetman AP. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore). 2005;84:98–106.CrossRef Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, Churchill D, de Ruiter A, Robinson S, Lacey CJ, Weetman AP. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore). 2005;84:98–106.CrossRef
35.
go back to reference Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–8.CrossRefPubMed Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–8.CrossRefPubMed
36.
go back to reference Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid. 2004;14:964–6.CrossRefPubMed Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid. 2004;14:964–6.CrossRefPubMed
37.
go back to reference Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid. 2006;16:225–36.CrossRefPubMed Benvenga S, Santarpia L, Trimarchi F, Guarneri F. Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid. 2006;16:225–36.CrossRefPubMed
38.
go back to reference Guarneri F, Carlotta D, Saraceno G, Trimarchi F, Benvenga S. Bioinformatics support the possible triggering of autoimmune thyroid disease by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid. 2011;21:1283–4.CrossRefPubMed Guarneri F, Carlotta D, Saraceno G, Trimarchi F, Benvenga S. Bioinformatics support the possible triggering of autoimmune thyroid disease by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid. 2011;21:1283–4.CrossRefPubMed
39.
go back to reference Gregoric E, Gregoric JA, Guarneri F, Benvenga S. Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine. 2011;39:41–7.CrossRefPubMed Gregoric E, Gregoric JA, Guarneri F, Benvenga S. Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine. 2011;39:41–7.CrossRefPubMed
40.
go back to reference Marangou A, Guarneri F, Benvenga S. Graves’ disease precipitated by rickettsial infection. Endocrine. 2015;50:828–9.CrossRefPubMed Marangou A, Guarneri F, Benvenga S. Graves’ disease precipitated by rickettsial infection. Endocrine. 2015;50:828–9.CrossRefPubMed
41.
go back to reference Guarneri F, Guarneri B. Bioinformatic analysis of HLA-linked genetic susceptibility to immunoallergic disease: the MotiFinder software. Ann Ital Dermatol Allergol. 2010;64:69–75. Guarneri F, Guarneri B. Bioinformatic analysis of HLA-linked genetic susceptibility to immunoallergic disease: the MotiFinder software. Ann Ital Dermatol Allergol. 2010;64:69–75.
42.
go back to reference Paparone PW. Hypothyroidism with concurrent Lyme disease. J Am Osteopath Assoc. 1995;95:435–7.PubMed Paparone PW. Hypothyroidism with concurrent Lyme disease. J Am Osteopath Assoc. 1995;95:435–7.PubMed
43.
go back to reference Völzke H, Werner A, Guertler L, Robinson D, Wallaschofski H, John U. Putative association between anti-Borrelia IgG and autoimmune thyroid disease? Thyroid. 2005;15:1273–7.CrossRefPubMed Völzke H, Werner A, Guertler L, Robinson D, Wallaschofski H, John U. Putative association between anti-Borrelia IgG and autoimmune thyroid disease? Thyroid. 2005;15:1273–7.CrossRefPubMed
44.
go back to reference Bech K, Larsen JH, Hansen JM, Nerup J. Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974;2:951–2.CrossRefPubMed Bech K, Larsen JH, Hansen JM, Nerup J. Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974;2:951–2.CrossRefPubMed
45.
go back to reference Lidman K, Eriksson U, Fagraeus A, Norberg R. Antibodies against thyroid cells in Yersinia enterocolitica infection. Lancet. 1974;2:1449.CrossRefPubMed Lidman K, Eriksson U, Fagraeus A, Norberg R. Antibodies against thyroid cells in Yersinia enterocolitica infection. Lancet. 1974;2:1449.CrossRefPubMed
46.
go back to reference Von Bonsdorff M, Friman C. Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974;2:1565–6.CrossRef Von Bonsdorff M, Friman C. Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974;2:1565–6.CrossRef
47.
go back to reference Arscott P, Rosen ED, Koenig RJ, Kaplan MM, Ellis T, Thompson N, Baker Jr JR. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 1992;75:295–300.PubMed Arscott P, Rosen ED, Koenig RJ, Kaplan MM, Ellis T, Thompson N, Baker Jr JR. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 1992;75:295–300.PubMed
48.
go back to reference Wenzel BE, Peters A, Zubaschev I. Bacterial virulence antigens and the pathogenesis of autoimmune thyroid disease (AITD). Exp Clin Endocrinol Diabetes. 1996;104(Suppl 4):75–8.CrossRefPubMed Wenzel BE, Peters A, Zubaschev I. Bacterial virulence antigens and the pathogenesis of autoimmune thyroid disease (AITD). Exp Clin Endocrinol Diabetes. 1996;104(Suppl 4):75–8.CrossRefPubMed
49.
go back to reference Chatzipanagiotou S, Legakis JN, Boufidou F, Petroyianni V, Nicolaou C. Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto’s thyroiditis. Clin Microbiol Infect. 2001;7:138–43.CrossRefPubMed Chatzipanagiotou S, Legakis JN, Boufidou F, Petroyianni V, Nicolaou C. Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto’s thyroiditis. Clin Microbiol Infect. 2001;7:138–43.CrossRefPubMed
50.
go back to reference Wang Z, Zhang Q, Lu J, Jiang F, Zhang H, Gao L, Zhao J. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotropin receptor antibodies in Graves’ disease and determination of its epitope using mass spectrometry and bioinformatics tools. J Clin Endocrinol Metab. 2010;95:4012–20.CrossRefPubMed Wang Z, Zhang Q, Lu J, Jiang F, Zhang H, Gao L, Zhao J. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotropin receptor antibodies in Graves’ disease and determination of its epitope using mass spectrometry and bioinformatics tools. J Clin Endocrinol Metab. 2010;95:4012–20.CrossRefPubMed
51.
go back to reference Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, Wren BW, Buckle AM, Dunn-Walters D, Banga JP. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves’ disease. J Immunol. 2013;190:5373–81.CrossRefPubMed Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, Wren BW, Buckle AM, Dunn-Walters D, Banga JP. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves’ disease. J Immunol. 2013;190:5373–81.CrossRefPubMed
52.
go back to reference Giménez-Barcons M, Colobran R, Gómez-Pau A, Marín-Sánchez A, Casteràs A, Obiols G, Abella R, Fernández-Doblas J, Tonacchera M, Lucas-Martín A, Pujol-Borrell R. Graves’ disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation? J Immunol. 2015;194:4199–206.CrossRefPubMed Giménez-Barcons M, Colobran R, Gómez-Pau A, Marín-Sánchez A, Casteràs A, Obiols G, Abella R, Fernández-Doblas J, Tonacchera M, Lucas-Martín A, Pujol-Borrell R. Graves’ disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation? J Immunol. 2015;194:4199–206.CrossRefPubMed
53.
go back to reference Hansen PS, Wenzel BE, Brix TH, Hegedüs L. Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study. Clin Exp Immunol. 2006;146:32–8.CrossRefPubMedPubMedCentral Hansen PS, Wenzel BE, Brix TH, Hegedüs L. Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study. Clin Exp Immunol. 2006;146:32–8.CrossRefPubMedPubMedCentral
54.
go back to reference Effraimidis G, Tijssen JG, Strieder TG, Wiersinga WM. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol. 2011;165:38–43.CrossRefPubMedPubMedCentral Effraimidis G, Tijssen JG, Strieder TG, Wiersinga WM. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol. 2011;165:38–43.CrossRefPubMedPubMedCentral
55.
go back to reference Vita R, Lapa D, Vita G, Trimarchi F, Benvenga S. A patient with stress-related onset and exacerbations of Graves’ disease. Nat Clin Pract Endocrinol Metab. 2009;5:55–61.CrossRefPubMed Vita R, Lapa D, Vita G, Trimarchi F, Benvenga S. A patient with stress-related onset and exacerbations of Graves’ disease. Nat Clin Pract Endocrinol Metab. 2009;5:55–61.CrossRefPubMed
56.
go back to reference Vita R, Lapa D, Trimarchi F, Benvenga S. Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine. 2015;48:254–63.CrossRefPubMed Vita R, Lapa D, Trimarchi F, Benvenga S. Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine. 2015;48:254–63.CrossRefPubMed
57.
go back to reference de Luis DA, Varela C, de La Calle H, Cantón R, de Argila CM, San Roman AL, Boixeda D. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998;26:259–63.CrossRefPubMed de Luis DA, Varela C, de La Calle H, Cantón R, de Argila CM, San Roman AL, Boixeda D. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998;26:259–63.CrossRefPubMed
58.
go back to reference Figura N, Di Cairano G, Lorè F, Guarino E, Gragnoli A, Cataldo D, Giannace R, Vaira D, Bianciardi L, Kristodhullu S, Lenzi C, Torricelli V, Orlandini G, Gennari C. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999;50:817–26.PubMed Figura N, Di Cairano G, Lorè F, Guarino E, Gragnoli A, Cataldo D, Giannace R, Vaira D, Bianciardi L, Kristodhullu S, Lenzi C, Torricelli V, Orlandini G, Gennari C. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol. 1999;50:817–26.PubMed
59.
go back to reference Franceschi F, Satta MA, Mentella MC, Penland R, Candelli M, Grillo RL, Leo D, Fini L, Nista EC, Cazzato IA, Lupascu A, Pola P, Pontecorvi A, Gasbarrini G, Genta RM, Gasbarrini A. Helicobacter pylori infection in patients with Hashimoto’s thyroiditis. Helicobacter. 2004;9:369.CrossRefPubMed Franceschi F, Satta MA, Mentella MC, Penland R, Candelli M, Grillo RL, Leo D, Fini L, Nista EC, Cazzato IA, Lupascu A, Pola P, Pontecorvi A, Gasbarrini G, Genta RM, Gasbarrini A. Helicobacter pylori infection in patients with Hashimoto’s thyroiditis. Helicobacter. 2004;9:369.CrossRefPubMed
60.
go back to reference Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B, Favret M, Manca N, Negrini R. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol. 2004;61:650–2.CrossRef Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B, Favret M, Manca N, Negrini R. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol. 2004;61:650–2.CrossRef
61.
go back to reference Tomasi PA, Dore MP, Fanciulli G, Sanciu F, Realdi G, Delitala G. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci. 2005;50:385–8.CrossRefPubMed Tomasi PA, Dore MP, Fanciulli G, Sanciu F, Realdi G, Delitala G. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci. 2005;50:385–8.CrossRefPubMed
62.
go back to reference Sterzl I, Hrda P, Potuznikova B, Matucha P, Hana V, Zamrazil V. Autoimmune thyroiditis and Helicobacter pylori-is there a connection? Neuro Endocrinol Lett. 2006;27(Suppl 1):41–5.PubMed Sterzl I, Hrda P, Potuznikova B, Matucha P, Hana V, Zamrazil V. Autoimmune thyroiditis and Helicobacter pylori-is there a connection? Neuro Endocrinol Lett. 2006;27(Suppl 1):41–5.PubMed
63.
go back to reference Sterzl I, Hrdá P, Matucha P, Cerovská J, Zamrazil V. Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res. 2008;57(Suppl 1):S135–41.PubMed Sterzl I, Hrdá P, Matucha P, Cerovská J, Zamrazil V. Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res. 2008;57(Suppl 1):S135–41.PubMed
64.
go back to reference Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and Graves’ disease. Helicobacter. 2010;15:558–62.CrossRefPubMed Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and Graves’ disease. Helicobacter. 2010;15:558–62.CrossRefPubMed
65.
go back to reference Bassi V, Marino G, Iengo A, Fattoruso O, Santinelli C. Autoimmune thyroid disease and Helicobacter pylori: the correlation is present only in Graves’ disease. World J Gastroenterol. 2012;18:1093–7.CrossRefPubMedPubMedCentral Bassi V, Marino G, Iengo A, Fattoruso O, Santinelli C. Autoimmune thyroid disease and Helicobacter pylori: the correlation is present only in Graves’ disease. World J Gastroenterol. 2012;18:1093–7.CrossRefPubMedPubMedCentral
66.
go back to reference Soveid M, Hosseini Asl K, Omrani GR. Infection by Cag A positive strains of Helicobacter pylori is associated with autoimmune thyroid disease in Iranian patients. Iran J Immunol. 2012;9:48–52.PubMed Soveid M, Hosseini Asl K, Omrani GR. Infection by Cag A positive strains of Helicobacter pylori is associated with autoimmune thyroid disease in Iranian patients. Iran J Immunol. 2012;9:48–52.PubMed
67.
go back to reference Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid disease: a meta-analysis. Thyroid. 2013;23:1294–300.CrossRefPubMed Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid disease: a meta-analysis. Thyroid. 2013;23:1294–300.CrossRefPubMed
68.
go back to reference Aghili R, Jafarzadeh F, Ghorbani R, Khamseh ME, Salami MA, Malek M. The association of Helicobacter pylori infection with Hashimoto’s thyroiditis. Acta Med Iran. 2013;51:293–6.PubMed Aghili R, Jafarzadeh F, Ghorbani R, Khamseh ME, Salami MA, Malek M. The association of Helicobacter pylori infection with Hashimoto’s thyroiditis. Acta Med Iran. 2013;51:293–6.PubMed
69.
go back to reference Arslan MS, Ekiz F, Deveci M, Sahin M, Topaloglu O, Karbek B, Tutal E, Ginis Z, Cakal E, Ozbek M, Yuksel O, Delibasi T. The relationship between cytotoxin-associated gene A positive Helicobacter pylori infection and autoimmune thyroid disease. Endocr Res. 2015;40:211–4.CrossRefPubMed Arslan MS, Ekiz F, Deveci M, Sahin M, Topaloglu O, Karbek B, Tutal E, Ginis Z, Cakal E, Ozbek M, Yuksel O, Delibasi T. The relationship between cytotoxin-associated gene A positive Helicobacter pylori infection and autoimmune thyroid disease. Endocr Res. 2015;40:211–4.CrossRefPubMed
70.
go back to reference El-Eshmawy MM, El-Hawary AK, Abdel Gawad SS, El-Baiomy AA. Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis. Diabetol Metab Syndr. 2011;3:28.CrossRefPubMedPubMedCentral El-Eshmawy MM, El-Hawary AK, Abdel Gawad SS, El-Baiomy AA. Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis. Diabetol Metab Syndr. 2011;3:28.CrossRefPubMedPubMedCentral
71.
go back to reference Zekry OA, Abd Elwahid HA. The association between Helicobacter pylori infection, type 1 diabetes mellitus, and autoimmune thyroiditis. J Egypt Public Health Assoc. 2013;88:143–7.CrossRefPubMed Zekry OA, Abd Elwahid HA. The association between Helicobacter pylori infection, type 1 diabetes mellitus, and autoimmune thyroiditis. J Egypt Public Health Assoc. 2013;88:143–7.CrossRefPubMed
72.
go back to reference Guarneri F, Alessi A, Trimarchi F, Benvenga S. Helicobacter pylori proteins and thyroid autoantigens share amino acid sequence homology that includes motifs of recognition for HLA molecules and T-cell receptors. 77th Annual meeting of the American Thyroid Association, Phoenix, AZ, USA, October 11–16, 2006. Thyroid. 2006;16:860–1 (Abstract). Guarneri F, Alessi A, Trimarchi F, Benvenga S. Helicobacter pylori proteins and thyroid autoantigens share amino acid sequence homology that includes motifs of recognition for HLA molecules and T-cell receptors. 77th Annual meeting of the American Thyroid Association, Phoenix, AZ, USA, October 11–16, 2006. Thyroid. 2006;16:860–1 (Abstract).
73.
go back to reference Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, Iannone AM, Solcia E. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab. 2006;91:176–9.CrossRefPubMed Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, Iannone AM, Solcia E. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab. 2006;91:176–9.CrossRefPubMed
74.
go back to reference Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, Shoenfeld Y. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev. 2008;8:112–5.CrossRefPubMed Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, Shoenfeld Y. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev. 2008;8:112–5.CrossRefPubMed
75.
go back to reference Shapira Y, Agmon-Levin N, Selmi C, Petríková J, Barzilai O, Ram M, Bizzaro N, Valentini G, Matucci-Cerinic M, Anaya JM, Katz BS, Shoenfeld Y. Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun. 2012;39:112–6.CrossRefPubMed Shapira Y, Agmon-Levin N, Selmi C, Petríková J, Barzilai O, Ram M, Bizzaro N, Valentini G, Matucci-Cerinic M, Anaya JM, Katz BS, Shoenfeld Y. Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun. 2012;39:112–6.CrossRefPubMed
76.
go back to reference Wasserman EE, Nelson K, Rose NR, Rhode C, Pillion JP, Seaberg E, Talor MV, Burek L, Eaton W, Duggan A, Yolken RH. Infection and thyroid autoimmunity: a seroepidemiologic study of TPOaAb. Autoimmunity. 2009;42:439–46.CrossRefPubMed Wasserman EE, Nelson K, Rose NR, Rhode C, Pillion JP, Seaberg E, Talor MV, Burek L, Eaton W, Duggan A, Yolken RH. Infection and thyroid autoimmunity: a seroepidemiologic study of TPOaAb. Autoimmunity. 2009;42:439–46.CrossRefPubMed
77.
go back to reference Kaňková Š, Procházková L, Flegr J, Calda P, Springer D, Potluková E. Effects of latent toxoplasmosis on autoimmune thyroid diseases in pregnancy. PLoS One. 2014;9:e110878.CrossRefPubMedPubMedCentral Kaňková Š, Procházková L, Flegr J, Calda P, Springer D, Potluková E. Effects of latent toxoplasmosis on autoimmune thyroid diseases in pregnancy. PLoS One. 2014;9:e110878.CrossRefPubMedPubMedCentral
78.
go back to reference Kiseleva EP, Mikhailopulo KI, Sviridov OV, Novik GI, Knirel YA, Szwajcer DE. The role of components of Bifidobacterium and Lactobacillus in pathogenesis and serologic diagnosis of autoimmune thyroid disease. Benefic Microbes. 2011;2:139–54.CrossRef Kiseleva EP, Mikhailopulo KI, Sviridov OV, Novik GI, Knirel YA, Szwajcer DE. The role of components of Bifidobacterium and Lactobacillus in pathogenesis and serologic diagnosis of autoimmune thyroid disease. Benefic Microbes. 2011;2:139–54.CrossRef
79.
go back to reference Felis GE, Dellaglio F, Torriani S. Taxonomy of probiotic microrganisms. In: Charalampopoulos D, Rastall RA, editors. Prebiotics and probiotics science and technology. New York: Springer; 2009. p. 591–637.CrossRef Felis GE, Dellaglio F, Torriani S. Taxonomy of probiotic microrganisms. In: Charalampopoulos D, Rastall RA, editors. Prebiotics and probiotics science and technology. New York: Springer; 2009. p. 591–637.CrossRef
80.
go back to reference Vojdani A, Rahimian P, Kalhor H, Mordechai E. Immunological cross reactivity between Candida albicans and human tissue. J Clin Lab Immunol. 1996;48:1–15.PubMed Vojdani A, Rahimian P, Kalhor H, Mordechai E. Immunological cross reactivity between Candida albicans and human tissue. J Clin Lab Immunol. 1996;48:1–15.PubMed
81.
go back to reference Khoury EL, Pereira L, Greenspan FS. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction. Am J Pathol. 1991;138:1209–23.PubMedPubMedCentral Khoury EL, Pereira L, Greenspan FS. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction. Am J Pathol. 1991;138:1209–23.PubMedPubMedCentral
82.
go back to reference Thomas D, Karachaliou F, Kallergi K, Vlachopapadopoulou E, Antonaki G, Chatzimarkou F, Fotinou A, Kaldrymides P, Michalacos S. Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine. 2008;33:171–5.CrossRefPubMed Thomas D, Karachaliou F, Kallergi K, Vlachopapadopoulou E, Antonaki G, Chatzimarkou F, Fotinou A, Kaldrymides P, Michalacos S. Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine. 2008;33:171–5.CrossRefPubMed
83.
go back to reference Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010;9:191–206.PubMed Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010;9:191–206.PubMed
84.
go back to reference Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.CrossRefPubMed Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.CrossRefPubMed
85.
go back to reference Fallahi P, Ferrari SM, Ruffilli I, Elia G, Giuggioli D, Colaci M, Ferri C, Antonelli A. Incidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-up. Autoimmun Rev. 2016. doi:10.1016/j.autrev.2016.03.012. Fallahi P, Ferrari SM, Ruffilli I, Elia G, Giuggioli D, Colaci M, Ferri C, Antonelli A. Incidence of thyroid disorders in mixed cryoglobulinemia: results from a longitudinal follow-up. Autoimmun Rev. 2016. doi:10.​1016/​j.​autrev.​2016.​03.​012.
86.
go back to reference Ferri S, Muratori L, Lenzi M, Granito A, Bianchi FB, Vergani D. HCV and autoimmunity. Curr Pharm Des. 2008;14:1678–85.CrossRefPubMed Ferri S, Muratori L, Lenzi M, Granito A, Bianchi FB, Vergani D. HCV and autoimmunity. Curr Pharm Des. 2008;14:1678–85.CrossRefPubMed
87.
go back to reference Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Mieli-Vergani G, Bianchi FB, Vergani D. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005;3:595–603.CrossRefPubMed Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Mieli-Vergani G, Bianchi FB, Vergani D. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005;3:595–603.CrossRefPubMed
89.
go back to reference Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-α. J Endocrinol Investig. 2011;34:78–84.CrossRef Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-α. J Endocrinol Investig. 2011;34:78–84.CrossRef
91.
go back to reference Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun. 2008;31:339–44.CrossRefPubMedPubMedCentral Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun. 2008;31:339–44.CrossRefPubMedPubMedCentral
Metadata
Title
Molecular mimicry and autoimmune thyroid disease
Authors
Salvatore Benvenga
Fabrizio Guarneri
Publication date
01-12-2016
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 4/2016
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9363-2

Other articles of this Issue 4/2016

Reviews in Endocrine and Metabolic Disorders 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine